Cerebrospinal fluid in Borna disease virus 1 (BoDV-1) encephalitis.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 03 2023
Historique:
received: 09 11 2022
accepted: 22 01 2023
pubmed: 31 1 2023
medline: 8 3 2023
entrez: 30 1 2023
Statut: ppublish

Résumé

Borna disease virus 1 (BoDV-1) has been recognized as a rare cause of very severe encephalitis with rapid onset in central Europe. Data on cerebrospinal fluid (CSF) analysis have not yet been analyzed in detail. Here, we present the first study on CSF changes in BoDV-1 encephalitis. We retrospectively analyzed CSFs from 18 BoDV-1 encephalitis cases from Bavaria, Germany, an endemic region, from 1996 to 2021. Data were obtained through review of medical records and institutional databases. We found that white blood cell count (WBC) in CSF is elevated in 13 of our 18 patients at first examination (average 83.2 ± 142.3 leukocytes/μl) and cytology showed predominance of lymphocytes. Patients with typical symptoms of meningoencephalitis had higher WBC in first CSF analyzation (133.5 ± 163.1 vs 4.0 ± 3.2/μl; p = 0.065). BoDV-1 PCR of CSF is not always positive when tested (7 of 9 cases). Four of five patients tested showed a polyvalent reaction against multiple viruses in the CSF suggesting that BoDV-1 may trigger autoimmune mechanisms. CSF changes in BoDV-1 encephalitis seem similar to those of other viral encephalitis and at the beginning WBC can be normal in up to 28%, making the diagnosis even more challenging. All in all, BoDV-1 should be included in the diagnostic workup of patients with rapidly evolving and/or severe encephalitis and patients with severe neuropathy and secondary encephalopathy with and without CSF changes. Repeated CSF examinations as well as BoDV-1 serology and CSF PCR have to be considered in endemic areas.

Identifiants

pubmed: 36716549
pii: S0022-510X(23)00028-X
doi: 10.1016/j.jns.2023.120568
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

120568

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no financial or other conflicts of interest related to the manuscript.

Auteurs

Bernhard Neumann (B)

Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany; Department of Neurology, Donau-Isar-Klinikum Deggendorf, Deggendorf, Germany.

Andreas Hierl (A)

Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany.

Silke Wunderlich (S)

Department of Neurology, Klinikum rechts der Isar der TU Muenchen, Muenchen, Germany.

Helen Meier (H)

Department of Neurology, Paracelsus Medizinische Privatuniversitaet, Klinikum Nürnberg, Nürnberg, Germany.

Christina Bauer (C)

Department of Neurology, Paracelsus Medizinische Privatuniversitaet, Klinikum Nürnberg, Nürnberg, Germany.

Stefan T Gerner (ST)

Department of Neurology, University Hospital Erlangen, Erlangen, Germany.

Georg Rieder (G)

Department of Neurology, Klinikum Traunstein, Traunstein, Germany.

Tobias Geis (T)

University Children's Hospital Regensburg (KUNO-Clinics) at St Hedwig Hospital, Hospital St. Hedwig of the Order of St. John, University of Regensburg, Regensburg, Germany.

Jürgen Kunkel (J)

University Children's Hospital of Regensburg (KUNO), Regensburg, Germany.

Markus Bauswein (M)

Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.

Hans Helmut Niller (HH)

Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.

Barbara Schmidt (B)

Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany.

Dennis Rubbenstroth (D)

Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.

Martin Beer (M)

Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.

Ralf A Linker (RA)

Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany.

Jonathan Jantsch (J)

Institute of Clinical Microbiology and Hygiene, Regensburg University Hospital, Regensburg, Germany; Institute for Medical Microbiology, Immunology, and Hygiene, University Hospital Cologne, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany.

Klemens Angstwurm (K)

Department of Neurology, University of Regensburg, Bezirksklinikum Regensburg, Regensburg, Germany. Electronic address: klemens.angstwurm@medbo.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH